Gyre Therapeutics's total assets for Q3 2025 were $159.38M, an increase of 4.41% from the previous quarter. GYRE total liabilities were $21.97M for the fiscal quarter, a -5.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.